SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study

COVID-19 generates SARS-CoV-2-specific antibodies in immunocompetent individuals. However, in immunocompromised patients, the humoral immunity following infection may be impaired or absent. Recently, the assessment of cellular immunity to SARS-CoV-2, both following natural infection and vaccination,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjöwall, Johanna, Hjorth, Maria, Gustafsson, Annette, Göransson, Robin, Larsson, Marie, Waller, Hjalmar, Nordgren, Johan, Nilsdotter-Augustinsson, Åsa, Nyström, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225567/
https://www.ncbi.nlm.nih.gov/pubmed/35743605
http://dx.doi.org/10.3390/jcm11123535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225567/
https://www.ncbi.nlm.nih.gov/pubmed/35743605
http://dx.doi.org/10.3390/jcm11123535

Ejemplares similares